Dave Fornell, ITN Editor
Dave Fornell, ITN Editor

Dave Fornell is the editor of Diagnostic & Interventional Cardiology magazine and assistant editor for Imaging Technology News magazine.

Blog | Dave Fornell, ITN Editor | Nuclear Imaging | May 03, 2019 | Dave Fornell, Editor

First Image of a Black Hole Shows Signs of Myocardial Ischemia

The first image of a black hole in space compared to a cardiac nuclear perfusion exam, showing the black hole of the left ventricle.

The first image of a black hole in space compared to a cardiac nuclear perfusion exam, showing the black hole of the left ventricle. Both the black hole and the cardiac scan show signs of a ischemic perfusion defect. 

This week, cardiologists learned for the first time they have been examining black holes for decades and did not know it. Many cardiologists and radiologists did a double take when they saw the ground-breaking first image of a black hole released by the U.S. National Science Foundation. While the unclear image of the dark circle surrounded by a bright neon orange and yellow was a new sight for many in science, it looked suspiciously similar to the standard nuclear myocardial perfusion imaging (MPI) exams many physicians have been looking at daily for the past 40 years. 

Nuclear MPI is used as the gold standard to determine if cardiac patients have a coronary artery blockage causing ischemia, or to detect areas of myocardial infarct from a heart attack. 

The breakthrough black hole image was announced in a series of six papers published in a special issue of The Astrophysical Journal Letters. The image reveals the black hole at the center of Messier 87, a massive galaxy in the nearby Virgo galaxy cluster. This black hole resides 55 million light-years from Earth and has a mass 6.5-billion times that of the sun. The black hole itself – a cosmic trapdoor from which neither light nor matter can escape – is unseeable. But the latest observations take astronomers right to its threshold for the first time, illuminating the event horizon beyond which all known physical laws collapse.

The image of the black hole was captured by the Event Horizon telescope (EHT), a network of eight radio telescopes in numerous locations, from Antarctica to Spain and Chile. The effort involved more than 200 scientists. “Black holes are the most mysterious objects in the universe. We have seen what we thought was unseeable. We have taken a picture of a black hole,” said Sheperd Doeleman, EHT director and Harvard University senior research fellow. 

Nuclear imaging scans are a little less mysterious and technically challenging to those in the know. But the close similarities to this image and nuclear MPI prompted many cardiologists and radiologists to post comments about it on clinical social media group pages. Many offered a preliminary diagnosis for the Messier 87 galaxy. 

At first glance, the galaxy appears to have a perfusion defect on the anterior wall of the left ventricle. However, several others piped in with comments that the galaxy clearly has large breasts and the perceived perfusion defect is actually an attenuation artifact caused by overlapping breast tissue, which causes issues with detection/photon counts to render the image properly, a common issue in this type of nuclear imaging. 

No one really wants to get their medical diagnosis from people they don't know on the internet, so I was really looking for a top expert's opinion to help with the clinical diagnosis of the Messier 87 galaxy black hole. I reached out to Kim Allan Williams, Sr., M.D., MACC, FAHA, MASNC, FESC, James B. Herrick Professor, chief, Division of Cardiology, Rush University Medical Center, and former president of both the American College of Cardiology (ACC) and American Society of Nuclear Cardiology (ASNC)

“Tell NASA that their Butterworth filter settings have a critical frequency that’s a little too low, resulting in thicker myocardial walls and a smaller LV chamber, but the black hole clearly has a critical LAD and ramus intermedius disease!” Williams responded after reviewing the black hole image.

Nuclear perfusion scans use SPECT or PET imaging detectors to visualize the radioactivity from radio tracers injected into the patient. The images show blood perfusion in the tissue and metabolic uptake of the radiotracer by the heart muscle.  

France Córdova, director of the U.S. National Science Foundation and an astrophysicist, said that the black hole image, which she had only seen as it was unveiled at the press briefing she was chairing, had brought tears to her eyes. “We have been studying black holes for so long that sometimes it’s easy to forget that none of us has seen one,” she said. “This will leave an imprint on people’s memories.” 

Ironically to see the same image, all she had to do was visit with any cardiology department and they could have fixed her up with a rarely easy to open CD of a similar image of the "black hole of the left ventricle," complete with quantification of the defect in the imaging report.

Cardiac nuclear imaging is stellar and we just did not know it.

 

Video Interviews With Kim Williams:

VIDEO: Use of Plant-Based Diet to Reduce Cardiovascular Disease Risk

VIDEO: Reducing Hypertension Among African-Americans

VIDEO: Imaging in the Assessment of Preventive Cardiology

Related Content

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images. #SCCT2020

The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images.

News | Computed Tomography (CT) | July 20, 2020
July 20, 2020 – To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA is
Tau (blue) and amyloid (orange) distribution patterns for super-agers, normal-agers and MCI patients, when compared to a group of younger, healthy, cognitively normal, amyloid-negative individuals. Brain projections are depicted at an uncorrected significance level of p < .0001. Color bars represent the respective t-statistic. Image courtesy of Merle C. Hoenig, Institute for Neuroscience and Medicine II - Molecular Organization of the Brain, Research Center Juelich, Juelich, Germany, and Department of Nucle

Tau (blue) and amyloid (orange) distribution patterns for super-agers, normal-agers and MCI patients, when compared to a group of younger, healthy, cognitively normal, amyloid-negative individuals. Brain projections are depicted at an uncorrected significance level of p < .0001. Color bars represent the respective t-statistic. Image courtesy of Merle C. Hoenig, Institute for Neuroscience and Medicine II - Molecular Organization of the Brain, Research Center Juelich, Juelich, Germany, and Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.

News | PET Imaging | July 16, 2020
July 16, 2020 — Super-agers, or individuals whose cognitive skills are above the norm even at an advanced age, have b
PSMA PET/CT accurately detects recurrent prostate cancer in 67-year-old man. 18F-DCFPyL-PSMA PET/CT shows extensive, intensely PSMA-avid local recurrence in prostate (bottom row; solid arrow) in keeping with the known tumor recurrence in the prostate. Right: PET shows extensive, intensely PSMA-avid local recurrence in prostate (top row; solid arrow) and a solitary bone metastasis in left rib 2 (bottom row; dotted arrow). Image courtesy of Ur Metser, et al.

PSMA PET/CT accurately detects recurrent prostate cancer in 67-year-old man. 18F-DCFPyL-PSMA PET/CT shows extensive, intensely PSMA-avid local recurrence in prostate (bottom row; solid arrow) in keeping with the known tumor recurrence in the prostate. Right: PET shows extensive, intensely PSMA-avid local recurrence in prostate (top row; solid arrow) and a solitary bone metastasis in left rib 2 (bottom row; dotted arrow). Image courtesy of Ur Metser, et al.

News | PET-CT | July 16, 2020
July 16, 2020 — New research confirms the high impact of...
Total-body dynamic 18F-FDG PET imaging with the uEXPLORER scanner allows us to monitor the spatiotemporal distribution of glucose concentration in metastatic tumors in the entire body (a). As compared to a typical clinical standardized uptake value image (b), the parametric image of FDG influx rate (Ki) can achieve higher lesion-to-background (e.g., the liver) contrast. In addition to glucose metabolism imaging by Ki, total-body dynamic PET also enables multiparametric characterization of tumors and organs

Total-body dynamic 18F-FDG PET imaging with the uEXPLORER scanner allows us to monitor the spatiotemporal distribution of glucose concentration in metastatic tumors in the entire body (a). As compared to a typical clinical standardized uptake value image (b), the parametric image of FDG influx rate (Ki) can achieve higher lesion-to-background (e.g., the liver) contrast. In addition to glucose metabolism imaging by Ki, total-body dynamic PET also enables multiparametric characterization of tumors and organs using additional physiologically important parameters, for example, glucose transport rate K1 (d), across the entire body. Image courtesy of G.B. Wang, M. Parikh, L. Nardo, et al., University of California Davis, Calif.

News | PET Imaging | July 16, 2020
July 16, 2020 — Results from the first...
The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

News | Cardiac Imaging | July 15, 2020
July 15, 2020 — ...
Representative maximum-intensity projection PET images of a healthy human volunteer injected with 64Cu-NOTA-EB-RGD at 1, 8, and 24 hours after injection. Axial MRI and PET slices of glioblastoma patient injected with 64Cu-NOTA-EB-RGD at different time points after injection. Image courtesy of Jingjing Zhang et al., Peking Union Medical College Hospital, Beijing, China/ Xiaoyuan Chen et al., Laboratory of Molecular Imaging and Nanomedicine, NIBIB/NIH, Bethesda, USA

Representative maximum-intensity projection PET images of a healthy human volunteer injected with 64Cu-NOTA-EB-RGD at 1, 8, and 24 hours after injection. Axial MRI and PET slices of glioblastoma patient injected with 64Cu-NOTA-EB-RGD at different time points after injection. Image courtesy of Jingjing Zhang et al., Peking Union Medical College Hospital, Beijing, China/ Xiaoyuan Chen et al., Laboratory of Molecular Imaging and Nanomedicine, NIBIB/NIH, Bethesda, USA

News | PET Imaging | July 15, 2020
July 15, 2020 — A first-in-human study presented at the Society of...
PET/CT imaging showing uptake and retention of 86Y-NM600 (imaging agent) in immunocompetent mice bearing prostate tumors. PET imaging data was employed to estimate tumor dosimetry and prescribe an immunomodulatory 90Y-NM600 (therapy agent) injected activity. Image courtesy of R Hernandez et al., University of Wisconsin-Madison, WI.

PET/CT imaging showing uptake and retention of 86Y-NM600 (imaging agent) in immunocompetent mice bearing prostate tumors. PET imaging data was employed to estimate tumor dosimetry and prescribe an immunomodulatory 90Y-NM600 (therapy agent) injected activity. Image courtesy of R Hernandez et al., University of Wisconsin-Madison, WI.

News | PET-CT | July 15, 2020
July 15, 2020 — ...